NCT06656416 - ALTO-100 in Bipolar Disorder With Depression (BD-D) | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

October 2, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

October 31, 2026

Conditions

Bipolar Disorder I or II With a Major Depressive Episode

Interventions

DRUG

ALTO-100

ALTO-100 40 mg tablet BID

DRUG

Placebo

Placebo tablet BID

Trial Locations (27)

20877

RECRUITING

Site 6062, Gaithersburg

21015

RECRUITING

Site 6076, Bel Air

21229

WITHDRAWN

Site 6151, Baltimore

30071

RECRUITING

Site 6064, Peachtree Corners

30328

RECRUITING

Site 6068, Atlanta

33319

WITHDRAWN

Site 6067, Lauderhill

44145

RECRUITING

Site 6075, Westlake

44720

RECRUITING

6065, North Canton

68526

RECRUITING

Site 6142, Lincoln

72204

RECRUITING

6070, Little Rock

72703

RECRUITING

6039, Fayetteville

77081

RECRUITING

Site 6072, Houston

80910

NOT_YET_RECRUITING

Site 6112, Colorado Springs

84020

NOT_YET_RECRUITING

Site 6121, Draper

85012

RECRUITING

Site 6000, Phoenix

85224

WITHDRAWN

Site 6036, Chandler

85364

RECRUITING

Site 6087, Yuma

87108

NOT_YET_RECRUITING

Site 6014, Albuquerque

87110

RECRUITING

Site 6078, Albuquerque

89102

RECRUITING

Site 6144, Las Vegas

89119

RECRUITING

Site 6104, Las Vegas

90025

RECRUITING

6069, Los Angeles

92056

RECRUITING

Site 6082, Oceanside

92251

RECRUITING

Site 6081, Imperial

92506

RECRUITING

Site 6102, Riverside

95655

NOT_YET_RECRUITING

Site 6016, Mather

08755

RECRUITING

Site 6066, Toms River